1. Synthetic Opioid Use and Common Injection-associated Viruses: Expanding the Translational Research Agenda
    Jason T. Blackard et al, 2019, Current HIV Research CrossRef
  2. Impact of Anesthetics, Analgesics, and Perioperative Blood Transfusion in Pediatric Cancer Patients: A Comprehensive Review of the Literature
    Juan P. Cata et al, 2019, Anesthesia & Analgesia CrossRef
  3. Targeting the mu-Opioid Receptor for Cancer Treatment
    Hao Zhang et al, 2021, Current Oncology Reports CrossRef
  4. The synthetic opioid fentanyl increases HIV replication and chemokine co-receptor expression in vitro
    Ling Kong et al, 2022, Journal of NeuroVirology CrossRef
  5. Mapping the Evidence for Opioid-Mediated Changes in Malignancy and Chemotherapeutic Efficacy: Protocol for a Scoping Review
    Jonathan E Constance et al, 2023, JMIR Research Protocols CrossRef
  6. Morphine Suppresses Liver Cancer Cell Tumor Properties In Vitro and In Vivo
    Hao-Wen Zhang et al, 2021, Frontiers in Oncology CrossRef
  7. Xanthomicrol suppresses human hepatocellular carcinoma cells migration and invasion ability via Μu-opioid receptor
    Zi-Zhong Lin et al, 2022, Journal of Pharmacy and Pharmacology CrossRef
  8. The synthetic opioid fentanyl enhances viral replication in vitro
    Ling Kong et al, 2021, PLOS ONE CrossRef
  9. Opioid Analgesic Agents and Cancer Cell Biology
    Nan Xie et al, 2015, Current Anesthesiology Reports CrossRef
  10. Drugs of Abuse and Their Impact on Viral Pathogenesis
    Jason Blackard et al, 2021, Viruses CrossRef
  11. Association of mu-opioid receptor expression with lymph node metastasis in esophageal squamous cell carcinoma
    Y.-F. Zhang et al, 2015, Diseases of the Esophagus CrossRef
  12. The μ-opioid receptor (MOR) promotes tumor initiation in hepatocellular carcinoma
    Yi Li et al, 2019, Cancer Letters CrossRef
  13. Chronic opioid therapy in long-term cancer survivors
    A. Carmona-Bayonas et al, 2017, Clinical and Translational Oncology CrossRef
  14. MOR1 Expression in Gastric Cancer: A Biomarker Associated With Poor Outcome
    Ya‐sai Yao et al, 2015, Clinical and Translational Science CrossRef
  15. The µ‐Opioid Receptor in Cancer and Its Role in Perineural Invasion: A Short Review and New Evidence
    Juan P. Cata et al, 2022, Advanced Biology CrossRef
  16. Opium Use and Risk of Pancreatic Cancer: A Prospective Cohort Study
    Shirin Moossavi et al, 2018, Cancer Epidemiology, Biomarkers & Prevention CrossRef
  17. Morphine promotes tumorigenesis and cetuximab resistance via EGFR signaling activation in human colorectal cancer
    Hong Lu et al, 2021, Journal of Cellular Physiology CrossRef
  18. Enhanced Recovery in Liver Surgery
    Bradford J. Kim et al, 2022, Colorectal Liver Metastasis CrossRef
  19. The mu-opioid receptor is a molecular marker for poor prognosis in hepatocellular carcinoma and represents a potential therapeutic target
    D.T. Chen et al, 2019, British Journal of Anaesthesia CrossRef
  20. The Synthetic Opioid Fentanyl Increases HIV Replication and Chemokine Co-Receptor Expression in Lymphocyte Cell Lines
    Janani Madhuravasal Krishnan et al, 2023, Viruses CrossRef
  21. The Impact of Drugs and Substance Abuse on Viral Pathogenesis—A South African Perspective
    Lufuno Ratshisusu et al, 2024, Viruses CrossRef
  22. The Various Functions of Opioids in Pathophysiological Conditions
    Huimin Gao et al, 2015, Neural Functions of the Delta-Opioid Receptor CrossRef